The Histories

SECTION 1.3

The Prima Solution was introduced to the public in the year 2107. Created by Dr. Helena Zefnerbach and her team at Prima Global, the Prima Solution was an inoculation believed to hold the potential for eradicating all illness. The drug was designed to serve as a biochemical advancement for the immune system, turning the body’s cells into elite organisms with the ability to destroy harmful bacteria, tumor cells, cancer stems, viruses, and all other antigens that triggered immune responses.

Prima Global, located in the Old American state of Minnesota, had been working on the miracle drug for over fifteen years before achieving results that could be replicated and were sustainable. The company drew national attention with its remarkable results and received significant funding from government grants, which allowed the facility to accelerate the project.

By the time the Prima Solution was released in 2107, scientists had discovered applications for the drug in all fields of immunology and virology as well as gerontology. Tests showed a slowing in the aging of human cells. Within weeks, demand for the product far exceeded production capabilities. The administered dose involved five different injections, three in the first twelve months, followed by two boosters over the next twenty-four months.

A large majority of recipients of the injection saw positive results, but a small group of individuals (1 in 10,000) failed to respond to the inoculations. Studies showed that some subjects had mutated cells that rejected the Prima Solution after the third injection. Dr. Zefnerbach and her team attempted to modify the formula for this mutation to no avail.

Despite the rare complications, the Prima Solution appeared to be a success. At the end of the first thirty-six months, illness and aging were already becoming anomalies rather than the norm. In 2110 the United Nations announced it would be working with the Red Cross to distribute the Prima Solution to all nations of the world. By 2111 the Prima Solution was on all seven continents, and the Red Cross had gained access to the most remote areas around the globe.

As a result, Prima Global grew exponentially and soon began building factories and plants in more than fifty countries, fueling its unprecedented trajectory to its status in 2112 as the most profitable company in history.

Yet as Dr. Zefnerbach’s major contribution to modern medicine reached around the globe, the urgency with which the product was pushed out allowed for an oversight that threatened the extinction of the world’s population.